Apheresis is a process in which blood of a donor/patient is passed through a medical device, which separates one or more components of blood and returns the remaining with or without extracorporeal treatment or replacement of separated component. This process involves devices and disposables that leverage centrifugation and membrane separation/filtration technologies to separate blood components.
The global market was valued at $1,140.8 million in 2012 and is expected to reach $1,922.4 million by 2017 growing at a CAGR of 11.0% from 2012 to 2017. The application of therapeutic apheresis for pediatric treatment is an uncaptured market and represents a prospective opportunity in the future.
This market is driven by the advantages of apheresis collection over the whole blood collection, huge demand for plasma in plasma fractionation and research for new applications of therapeutic apheresis. However, the cost of capital investment involved and the challenges in recruiting donors for apheresis collection are inhibiting the growth of this market.
The market studied in this report is segmented by procedure, application, technology, product type, and end-user. Based on the rationale of the apheresis procedure, the market is segmented as automated blood collection (donor) and therapeutic apheresis. Automated blood collection accounts for the largest share of the global market, by procedure, in 2012. The application market is divided into plasmapheresis, plateletpheresis, erythrocytapheresis, leukapheresis and others, while technology market is classified as centrifugation & membrane separation/filtration in which the former leads the market in 2012
Get PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=950
Increasing blood shortage, advantages of apheresis collection over whole blood and increasing demand for plasma from biopharmaceutical companies are the major drivers that are slated to propel this market. However, donor recruitment and high cost of the apheresis are the major challenges for the growth. The application of therapeutic apheresis for pediatric treatment is an uncaptured market and represents a prospective opportunity in the future.
North America holds the largest market share of close to 50%, followed by Europe in 2012. In the next five years, emerging countries are estimated to register the highest growth rate, primarily due to increasing investments and huge demand for blood components from countries like China and India with large population.
Ask for Discount on Report: http://www.marketsandmarkets.com/discountreports.asp?id=950
The key players in the market are Haemonetics Corporation (U.S.), FRESENIUS MEDICAL CARE (Germany), Terumo BCT, Inc. (U.S.), Asahi Kasei Medical Co., Ltd. (Japan), Kawasumi Laboratories Inc (Japan), and HemaCare Corporation (U.S.), with Haemonetics leading the pack.
MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.
MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers thirteen industry verticals; including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods, telecommunications and IT, energy and power, food and beverages, industrial automation, healthcare IT, medical devices, pharmaceuticals, semiconductor and electronics, aerospace & defense.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
North - Dominion Plaza
17304 Preston Road
Suite 800, Dallas, TX 75252
Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/medical-devices
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets